Increased levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in cerebrospinal fluid and brain parenchyma were detected in patients with depression (Enache et al., 2019). The gene discussed is TNF; the disease is depressive symptom measurement.